Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by IGC Pharma, Inc. IGC Pharma's TGR-63 Preclinical Results Show Substantial Reduction in Amyloid Plaque, a Key Hallmark of Alzheimer's Disease June 25, 2024 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC Reports Financial Results for Fiscal Year Ended March 31, 2024 June 24, 2024 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets June 18, 2024 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta 9 Tetrahydrocannabinol June 10, 2024 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two April 16, 2024 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC Pharma Adds Advisor in Artificial Intelligence April 09, 2024 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation March 20, 2024 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024 March 20, 2024 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline March 12, 2024 From IGC Pharma, Inc. Via Business Wire Tickers IGC Promising Results: TGR-63 Enhances Memory in Alzheimer's Mouse Model February 28, 2024 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a “Buy” Recommendation and $3.00 Price Target February 23, 2024 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC Pharma Reports Third Quarter Fiscal 2024 Results February 16, 2024 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's Mouse Model February 01, 2024 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63 Reduces Plaque in Alzheimer’s January 23, 2024 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing Phase 2b Alzheimer’s Trial January 17, 2024 From IGC Pharma, Inc. Via Business Wire Tickers IGC Patent Granted to IGC Pharma for Groundbreaking Drug Formulation to Treat Agitation in Alzheimer’s December 19, 2023 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC Pharma Announces Participation in Biotech Showcase and BioPartnering @ JPM Alongside the J.P. Morgan 41st Annual Healthcare Conference 2024 December 13, 2023 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC Pharma Announces Collaboration to Integrate AI into Clinical Trials December 06, 2023 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC Pharma Announces Master Agreement with Leading South American University to Advance AI Initiatives November 21, 2023 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC Pharma Reports Second Quarter Fiscal 2024 Results November 13, 2023 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC Pharma Granted European Patent for Groundbreaking Cannabinoid-Based Pain Topical Relief Therapy October 19, 2023 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC Announces Results of its 2023 Annual Stockholders Meeting August 21, 2023 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC Pharma Reports First Quarter Results; Company Continues to Make Significant Progress Advancing Its Lead Alzheimer’s Candidate Through Phase 2 Clinical Trials August 14, 2023 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC Pharma Expands Phase 2 Trial of IGC-AD1 to Include the University of Puerto Rico August 02, 2023 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC Pharma, Inc. Presenting 6 Posters on the Positive Impact of IGC-AD1 on Neuropsychiatric Symptoms in Dementia at the 2023 Alzheimer’s Association International Conference July 18, 2023 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC Reports Financial Results for Fiscal Year Ended March 31, 2023 July 12, 2023 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC Pharma Secures $12 Million Line of Credit from O-Bank Strengthening Efforts in Alzheimer's Research July 07, 2023 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC Pharma Announces a $3 Million Private Placement of its Common Stock July 06, 2023 From IGC Pharma, Inc. Via Business Wire Tickers IGC IGC Pharma Receives Notice of Allowance for Patent on Seizures June 06, 2023 From IGC Pharma, Inc. Via Business Wire Tickers IGC Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.